| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACRP30, a new hormone controlling fat and glucose metabolism
|
Tsao, Tsu-Shuen
|
|
2002
|
440 |
2-3 |
p. 213-221
9 p.
|
artikel
|
| 2 |
β3-Adrenoceptor agonists: potential, pitfalls and progress
|
Arch, Jonathan R.S.
|
|
2002
|
440 |
2-3 |
p. 99-107
9 p.
|
artikel
|
| 3 |
Author index
|
|
|
2002
|
440 |
2-3 |
p. 291-292
2 p.
|
artikel
|
| 4 |
Bombesin and its family of peptides: prospects for the treatment of obesity
|
Yamada, Kazuyuki
|
|
2002
|
440 |
2-3 |
p. 281-290
10 p.
|
artikel
|
| 5 |
Galanin/GALP and galanin receptors: role in central control of feeding, body weight/obesity and reproduction?
|
Gundlach, Andrew L
|
|
2002
|
440 |
2-3 |
p. 255-268
14 p.
|
artikel
|
| 6 |
Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives
|
Meier, Juris J.
|
|
2002
|
440 |
2-3 |
p. 269-279
11 p.
|
artikel
|
| 7 |
Keyword index
|
|
|
2002
|
440 |
2-3 |
p. 293-297
5 p.
|
artikel
|
| 8 |
Leptin and the treatment of obesity: its current status
|
Lee, Daniel W
|
|
2002
|
440 |
2-3 |
p. 129-139
11 p.
|
artikel
|
| 9 |
Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity
|
Muccioli, Giampiero
|
|
2002
|
440 |
2-3 |
p. 235-254
20 p.
|
artikel
|
| 10 |
Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status
|
Parker, Eric
|
|
2002
|
440 |
2-3 |
p. 173-187
15 p.
|
artikel
|
| 11 |
Orexins and the treatment of obesity
|
Smart, Darren
|
|
2002
|
440 |
2-3 |
p. 199-212
14 p.
|
artikel
|
| 12 |
Orlistat: its current status as an anti-obesity drug
|
Ballinger, Anne
|
|
2002
|
440 |
2-3 |
p. 109-117
9 p.
|
artikel
|
| 13 |
Peroxisome proliferator activated receptors and obesity
|
Kersten, Sander
|
|
2002
|
440 |
2-3 |
p. 223-234
12 p.
|
artikel
|
| 14 |
Preface
|
Adan, Roger
|
|
2002
|
440 |
2-3 |
p. 83-84
2 p.
|
artikel
|
| 15 |
The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance
|
Richard, Denis
|
|
2002
|
440 |
2-3 |
p. 189-197
9 p.
|
artikel
|
| 16 |
The discovery and status of sibutramine as an anti-obesity drug
|
Luque, Carla A.
|
|
2002
|
440 |
2-3 |
p. 119-128
10 p.
|
artikel
|
| 17 |
The role of melanocortins in body weight regulation: opportunities for the treatment of obesity
|
MacNeil, Douglas J.
|
|
2002
|
440 |
2-3 |
p. 141-157
17 p.
|
artikel
|
| 18 |
Thyroid hormones in the pathogenesis and treatment of obesity
|
Krotkiewski, Marcin
|
|
2002
|
440 |
2-3 |
p. 85-98
14 p.
|
artikel
|
| 19 |
Ups and downs for neuropeptides in body weight homeostasis: pharmacological potential of cocaine amphetamine regulated transcript and pre-proglucagon-derived peptides
|
Larsen, Philip J
|
|
2002
|
440 |
2-3 |
p. 159-172
14 p.
|
artikel
|
Tijdschrift beschrijving